PIMA547585

Canine/Feline Parvovirus Monoclonal Antibody (7353), Invitrogen™

Manufacturer: Thermo Scientific

Select a Size

Pack Size SKU Availability Price
Each of 1 PIMA547585-Each-of-1 In Stock ₹ 42,987.00

PIMA547585 - Each of 1

₹ 42,987.00

In Stock

Quantity

1

Base Price: ₹ 42,987.00

GST (18%): ₹ 7,737.66

Total Price: ₹ 50,724.66

Antigen

Canine/Feline Parvovirus

Classification

Monoclonal

Concentration

100 μg/mL

Formulation

PBS with 0.1% sodium azide, pH 7.2

Host Species

Mouse

Purification Method

Protein A

Regulatory Status

RUO

Target Species

Virus

Form

Liquid

Applications

ELISA, Immunocytochemistry

Clone

7353

Conjugate

Unconjugated

Gene Alias

CPV, FPV, parvo

Immunogen

Proprietary sequence

Quantity

100 μg

Primary or Secondary

Primary

Content And Storage

4° C

Isotype

IgG1

Related Products

Img

Thermo Scientific

PIMA518185

--

Img

Thermo Scientific

PIMA544546

--

Img

Thermo Scientific

PIMA526705

--

Img

Novus Biologicals

NB502655

--

Img

Thermo Scientific

PIPA540467

--

Img

Novus Biologicals

NBP242634F

--

Img

Novus Biologicals

NP20114A32

--

Img

Thermo Scientific

PIPA5113164

--

Description

  • Specificity: Reactive with CPV and Feline Panleukopenia virus
  • Best Antibody Pairs for Antigen Detection (capture/conjugate): Canine/Feline Parvovirus Monoclonal antibody (Product # MA5-47585)/Canine Parvovirus Polyclonal antibody (Product # MA1-7467)
  • Purified preparations consist of >90% pure mouse monoclonal antibody which has been purified from ascites fluid by protein A chromatography
  • The final preparation is formulated to a protein concentration of 100 μg/mL in 0.01 M phosphate buffered saline, pH 7.2 and contains 0.1% sodium azide
  • Each vial contains 1.0 mL
  • This product contains no stabilizing proteins and should be stored at 4C until ready for use
  • Working dilution must be determined by the user
  • Suggested starting ranges are 1:10-1:50 for ICC/IF and 1:20-1:200
  • for ELISA
  • CPV is reported to be a host range variant of FPV which emerged as a result of mutations of the viral capsid.